Inventor · disambiguated record
Yu Na Chae
Also filed as: CHAE YU-NA
5 granted patents·4 pending applications·4 citations·filing 2008–2021
67Inventor score
Top patents by PatentIndex Score
9 records- 0174US10428055B2Substituted piperidines having GPR119 agonistic activityDONG A ST CO LTD·Filed 2015·Granted Oct 1, 2019·2 cites·17 claims
- 0270US12115159B2Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containing GPR119 ligand as active ingredientDONG A ST CO LTD·Filed 2019·Granted Oct 15, 2024·1 cites·5 claims
- 0361US8440669B2Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredientsSHIN CHANG YELL·Filed 2009·Granted May 14, 2013·1 cites·25 claims
- 0460US11713344B2Acylated oxyntomodulin peptide analogDONG A ST CO LTD·Filed 2021·Granted Aug 1, 2023·0 cites·14 claims
- 0557US11236142B2Acylated oxyntomodulin peptide analogDONG A ST CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·9 claims
- 0651US2023143119A1Pharmaceutical composition for prevention or treatment of diabetes and metabolic diseases associated therewithDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 0750US2023220035A1Long-acting glp-1 and glucagon receptor dual agonistDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 0843US2010063041A1Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the sameMOON HO-SANG·Filed 2008·Application pending·0 cites
- 0931US2013072459A1Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the sameAN GOOK-JUN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu Na Chae files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →